Metformin Add-on Regimen Comparison Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431A-136)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 337 participants.

Also called NCT01545388

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 337 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01545388
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01545388. Randomized; double masking; primary purpose treatment. Start 2012-02-23 (actual); primary completion 2013-03-12 (actual). Results posted on 2014-03-26.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Metformin Add-on Regimen Comparison Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431A-136)
Condition
Type 2 Diabetes Mellitus
Intervention (Drug)
Sitagliptin
Intervention (Drug)
Metformin
Intervention (Drug)
Metformin
Intervention (Drug)
Placebo
Lead sponsor
Merck Sharp & Dohme LLC (class: industry)

Record details

Record id
cardio:ct-nct01545388
Content hash
2c621ff54351e986ae0b3a3bb803c7804385b7b9c5300c69eaeefcec53d92dde